Diversity of individual dynamic patterns of emergence of resistance to quinolones in Escherichia coli from the fecal flora of healthy volunteers exposed to ciprofloxacin

Journal of Infectious Diseases

Volumn 206, Issue 9, 2012, Pages 1399-1406

  De Lastours, Victoire ^a,b   Cambau, Emmanuelle ^a,c   Guillard, Thomas ^a   Marcade, Géraldine ^a,c   Chau, Françoise ^a   Fantin, Bruno ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BEAUJON HOSPITAL   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; LEVOFLOXACIN; NALIDIXIC ACID; OFLOXACIN; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CARRIER; BACTERIUM DETECTION; CONTROLLED STUDY; DRUG EXPOSURE; DRUG FECES LEVEL; ESCHERICHIA COLI; FECES ANALYSIS; FECES MICROFLORA; GENE MUTATION; GENOTYPE; GYRA GENE; HUMAN; HUMAN EXPERIMENT; MICROBIAL DIVERSITY; MINIMUM INHIBITORY CONCENTRATION; MUTANT; NONHUMAN; NORMAL HUMAN; PARC GENE; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FECES; HUMAN EXPERIMENTATION; HUMANS; MOLECULAR TYPING; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SELECTION, GENETIC;

EID: 84867528871     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis511     Document Type: Article

References (39)

1. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother 2009; 64(Suppl 1):i3-10.
2. Rice LB. The clinical consequences of antimicrobial resistance. Curr Opin Microbiol 2009; 12:476-81.
3. Sommer MOA, Dantas G, Church GM. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 2009; 325:1128-31.
4. Andremont A. Role of the commensal flora in the spread of bacterial resistance: The invisible collateral damage of antibiotic treatments ASM News 2003; 69:601-7.
5. Salyers AA, Gupta A, Wang Y. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol 2004; 12:412-6. (Pubitemid 39178592)
6. Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001; 1:101-14. (Pubitemid 33586045)
7. Andremont A, Brun-Buisson C, Struelens M. Evaluating and predicting the ecologic impact of antibiotics. Clin Microbiol Infect 2001; 7(Suppl 5):1-6.
8. Richard P, Delangle MH, Raffi F, Espaze E, Richet H. Impact of fluoroquinolone administration on the emergence of fluoroquinoloneresistant gram-negative bacilli from gastrointestinal flora. Clin Infect Dis 2001; 32:162-6. (Pubitemid 32150964)
9. Dupeyron C, Mangeney N, Sedrati L, Campillo B, Fouet P, Leluan G. Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis. Antimicrob Agents Chemother 1994; 38:340-4. (Pubitemid 24054258)
10. Carratala J, Fernandez-Sevilla A, Tubau F, Dominguez MA, Gudiol F. Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrob Agents Chemother 1996; 40:503-5. (Pubitemid 26049371)
11. Putnam SD, Sanders JW, Tribble DR, et al. Posttreatment changes in Escherichia coli antimicrobial susceptibility rates among diarrheic patients treated with ciprofloxacin. Antimicrob Agents Chemother 2005; 49:2571-2. (Pubitemid 40734510)
12. Fantin B, Duval X, Massias L, et al. Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. J Infect Dis 2009; 200:390-8.
13. de Lastours V, Chau F, Tubach F, Pasquet B, Ruppé E, Fantin B. Independent behavior of commensal flora for carriage of fluoroquinolone- resistant bacteria in patients at admission. Antimicrob Agents Chemother 2010; 54:5193-200.
14. Lautenbach E, Metlay JP, Mao X, et al. The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clin Infect Dis 2010; 51:280-5.
15. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4554-61.
16. Pecquet S, Ravoire S, Andremont A. Fecal excretion of ciprofloxacin after a single oral dose and its effect on fecal bacteria in healthy volunteers. J Antimicrob Chemother 1990; 26:125-9. (Pubitemid 20263705)
17. Steers E, Foltz EL, Graves BS, Suriano HJ. Comparison of bacterial susceptibility to antibiotics as determined by the plate dilution method and by the disc method. Antibiot Annu 1959; 7:604-13.
18. Guillard T, Moret H, Brasme L, et al. Rapid detection of qnr and qepA plasmid-mediated quinolone resistance genes using real-time PCR. Diagn Microbiol Infect Dis 2011; 70:253-9.
19. Guillard T, Duval V, Moret H, Brasme L, Vernet-Garnier V, de Champs C. Rapid detection of aac(6′)-Ib-cr quinolone resistance gene by pyrosequencing. J Clin Microbiol 2010; 48:286-9.
20. Cagnacci S, Gualco L, Debbia E, Schito GC, Marchese A. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J Clin Microbiol 2008; 46:2605-12.
21. Clermont O, Dhanji H, Upton M, et al. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 2009; 64:274-7.
22. Johnson JR, Owens K, Sabate M, Prats G. Rapid and specific detection of the O15:K52:H1 clonal group of Escherichia coli by gene-specific PCR. J Clin Microbiol 2004; 42:3841-3.
23. Nowrouzian F, Hesselmar B, Saalman R, et al. Escherichia coli in infants' intestinal microflora: Colonization rate, strain turnover, and virulence gene carriage. Pediatr Res 2003; 54:8-14. (Pubitemid 36736798)
24. Branger C, Bruneau B, Lesimple AL, et al. Epidemiological typing of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates responsible for five outbreaks in a university hospital. J Hosp Infect 1997; 36:23-36. (Pubitemid 27235033)
25. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-9.
26. Vollaard EJ, Clasener HA. Colonization resistance. Antimicrob Agents Chemother 1994; 38:409-4.
27. Duval-Iflah Y, Raibaud P, Tancrede C, Rousseau M. R-plasmic transfer from Serratia liquefaciens to Escherichia coli in vitro and in vivo in the digestive tract of gnotobiotic mice associated with human fecal flora. Infect Immun 1980; 28:981-90. (Pubitemid 10122532)
28. Marshall B, Petrowski D, Levy SB. Inter-and intraspecies spread of Escherichia coli in a farm environment in the absence of antibiotic usage. Proc Natl Acad Sci U S A 1990; 87:6609-13.
29. Johnson JR, Kuskowski MA, Menard M, Gajewski A, Xercavins M, Garau J. Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status. J Infect Dis 2006; 194:71-8.
30. Qin X, Razia Y, Johnson JR, et al. Ciprofloxacin-resistant gramnegative bacilli in the fecal microflora of children. Antimicrob Agents Chemother 2006; 50:3325-9. (Pubitemid 44527505)
31. Johnson JR, Anderson JT, Clabots C, Johnston B, Cooperstock M. Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection. Pediatr Infect Dis J 2010; 29:473-5.
32. Mihaila L, Wyplosz B, Clermont O, et al. Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phylogenetic subgroup D2 O102-ST405 clone. J Antimicrob Chemother 2010; 65:1537-9.
33. Owens RC Jr, Johnson JR, Stogsdill P, Yarmus L, Lolans K, Quinn J. Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death. J Clin Microbiol 2011; 49:3406-8.
34. Walson JL, Marshall B, Pokhrel BM, Kafle KK, Levy SB. Carriage of antibiotic-resistant fecal bacteria in Nepal reflects proximity to Kathmandu. J Infect Dis 2001; 184:1163-9. (Pubitemid 33010469)
35. Corpet DE. An evaluation of methods to assess the effect of antimicrobial residues on the human gut flora. Vet Microbiol 1993; 35:199-212.
36. Ruimy R, Brisabois A, Bernede C, et al. Organic and conventional fruits and vegetables contain equivalent counts of Gram-negative bacteria expressing resistance to antibacterial agents. Environ Microbiol 2010; 12:608-15.
37. Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas-Chanoine M-H. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol 2008; 46:3900-5.
38. Marcusson LL, Frimodt-Møller N, Hughes D. Interplay in the selection of fluoroquinolone resistance and bacterial fitness. PLoS Pathog 2009; 5:e1000541.
39. Lidin-Janson G, Kaijser B, Lincoln K, Olling S, Wedel H. The homogeneity of the fecal coliform flora of normal school-girls, characterized by serological and biochemical properties. Med Microbiol Immunol 1978; 164:247-53. (Pubitemid 8315221)